Clinical Trial Update: Spironolactone in CKD Enabled by Chlorthalidone: PILOT [Phase 2]

View source ↗

Summary

A Phase 2 trial update for Spironolactone in chronic kidney disease enabled by chlorthalidone (PILOT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Chlorthalidone (chlorthalidone)
• Spironolactone (spironolactone)

Snippet

Sponsor: Indiana Institute for Medical Research | Conditions: Renal Insufficiency, Chronic Hypertension | Phase 2 | Status: UNKNOWN